He H - Search Results

1

MicroRNAs-based network: a novel therapeutic agent in pituitary adenoma.

Shi X, Tao B, He H, Sun Q, Fan C, Bian L, Zhao W, Lu YC. Shi X, et al. Among authors: he h. Med Hypotheses. 2012 Mar;78(3):380-4. doi: 10.1016/j.mehy.2011.12.001. Epub 2012 Jan 4. Med Hypotheses. 2012. PMID: 22222153 Review.

2

Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.

Zhao Z, Liu Y, He H, Chen X, Chen J, Lu YC. Zhao Z, et al. Among authors: he h. Brain Res Bull. 2011 Oct 10;86(3-4):189-94. doi: 10.1016/j.brainresbull.2011.07.010. Epub 2011 Jul 22. Brain Res Bull. 2011. PMID: 21807073

3

Knockdown of CDK6 enhances glioma sensitivity to chemotherapy.

Li B, He H, Tao BB, Zhao ZY, Hu GH, Luo C, Chen JX, Ding XH, Sheng P, Dong Y, Zhang L, Lu YC. Li B, et al. Among authors: he h. Oncol Rep. 2012 Sep;28(3):909-14. doi: 10.3892/or.2012.1884. Epub 2012 Jun 25. Oncol Rep. 2012. PMID: 22736304

4

Neuronal transcription factors induce conversion of human glioma cells to neurons and inhibit tumorigenesis.

Zhao J, He H, Zhou K, Ren Y, Shi Z, Wu Z, Wang Y, Lu Y, Jiao J. Zhao J, et al. Among authors: he h. PLoS One. 2012;7(7):e41506. doi: 10.1371/journal.pone.0041506. Epub 2012 Jul 31. PLoS One. 2012. PMID: 22859994 Free PMC article.

5

Up-regulation of USP2a and FASN in gliomas correlates strongly with glioma grade.

Tao BB, He H, Shi XH, Wang CL, Li WQ, Li B, Dong Y, Hu GH, Hou LJ, Luo C, Chen JX, Chen HR, Yu YH, Sun QF, Lu YC. Tao BB, et al. Among authors: he h. J Clin Neurosci. 2013 May;20(5):717-20. doi: 10.1016/j.jocn.2012.03.050. Epub 2013 Feb 14. J Clin Neurosci. 2013. PMID: 23416128

6

Downregulation of Id2 increases chemosensitivity of glioma.

Zhao Z, He H, Wang C, Tao B, Zhou H, Dong Y, Xiang J, Wang L, Luo C, Lu Y, Yu X. Zhao Z, et al. Among authors: he h. Tumour Biol. 2015 Jun;36(6):4189-96. doi: 10.1007/s13277-015-3055-5. Epub 2015 Mar 14. Tumour Biol. 2015. PMID: 25773386

7

MEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatment.

He H, Yao M, Zhang W, Tao B, Liu F, Li S, Dong Y, Zhang C, Meng Y, Li Y, Hu G, Luo C, Zong H, Lu Y. He H, et al. Cell Mol Immunol. 2016 Sep;13(5):658-68. doi: 10.1038/cmi.2015.46. Epub 2015 Jul 20. Cell Mol Immunol. 2016. PMID: 26189368 Free PMC article.

8

Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.

Li B, Wang Y, Li S, He H, Sun F, Wang C, Lu Y, Wang X, Tao B. Li B, et al. Among authors: he h. Int J Clin Exp Pathol. 2015 Jun 1;8(6):7016-21. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261592 Free PMC article.

9

RIZ1: a potential tumor suppressor in glioma.

Zhang C, Zhu Q, He H, Jiang L, Qiang Q, Hu L, Hu G, Jiang Y, Ding X, Lu Y. Zhang C, et al. Among authors: he h. BMC Cancer. 2015 Dec 21;15:990. doi: 10.1186/s12885-015-2023-1. BMC Cancer. 2015. PMID: 26690953 Free PMC article.

10

Erratum to: RIZ1: a potential tumor suppressor in glioma.

Zhang C, Zhu Q, He H, Jiang L, Qiang Q, Hu L, Hu G, Jiang Y, Ding X, Lu Y. Zhang C, et al. Among authors: he h. BMC Cancer. 2016 Jan 18;16:26. doi: 10.1186/s12885-016-2067-x. BMC Cancer. 2016. PMID: 26781093 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,027 results

Search Page

Filters